Generex Biotechnology Corp (GNBTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 04-2021 | 01-2021 | 10-2020 | 07-2020 | 04-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,910 | -35,396 | -10,989 | -34,232 | -22,353 |
| Depreciation Amortization | 783 | 524 | 262 | 9,658 | 609 |
| Accounts receivable | 113 | -5 | -19 | -6 | 17 |
| Other Working Capital | 25,618 | 18,961 | 9,860 | 10,085 | 6,073 |
| Other Operating Activity | -1,343 | 13,600 | -450 | 8,374 | 10,168 |
| Operating Cash Flow | $-1,739 | $-2,316 | $-1,336 | $-6,121 | $-5,487 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -5 | -5 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 49 |
| Other Investing Activity | 0 | 0 | 0 | 49 | 0 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $45 | $45 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,050 | N/A | N/A | 6,636 | 6,381 |
| Debt Repayment | -2,365 | -128 | -60 | N/A | -926 |
| Common Stock Issued | 3,713 | 3,024 | 2,216 | 110 | 110 |
| Other Financing Activity | 0 | 0 | 0 | -936 | 0 |
| Financing Cash Flow | $3,399 | $2,896 | $2,156 | $5,811 | $5,566 |
| Exchange Rate Effect | N/A | N/A | -2 | -17 | N/A |
| Beginning Cash Position | 16 | 16 | 16 | 299 | 299 |
| End Cash Position | 1,675 | 596 | 834 | 16 | 417 |
| Net Cash Flow | $1,660 | $581 | $818 | $-283 | $118 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,739 | -2,316 | -1,336 | -6,121 | -5,487 |
| Capital Expenditure | N/A | N/A | N/A | -5 | -5 |
| Free Cash Flow | -1,739 | -2,316 | -1,336 | -6,126 | -5,492 |